First Horizon Advisors, Inc. 10x Genomics, Inc. Transaction History
First Horizon Advisors, Inc.
- $3.58 Billion
- Q3 2024
A detailed history of First Horizon Advisors, Inc. transactions in 10x Genomics, Inc. stock. As of the latest transaction made, First Horizon Advisors, Inc. holds 2,910 shares of TXG stock, worth $43,359. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,910
Previous 1,898
53.32%
Holding current value
$43,359
Previous $36,000
80.56%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding TXG
# of Institutions
292Shares Held
96.6MCall Options Held
263KPut Options Held
85.1K-
Vanguard Group Inc Valley Forge, PA11MShares$163 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl10.8MShares$160 Million2.31% of portfolio
-
Morgan Stanley New York, NY6.48MShares$96.5 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.39MShares$95.3 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.6.37MShares$95 Million0.1% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $1.42B
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...